Syngen Biotech Market Cap

Syngen Biotech has a market cap or net worth of 3.51 billion as of February 21, 2025. Its market cap has decreased by -16.72% in one year.

Market Cap

3.51B

Enterprise Value

3.70B

Revenue

2.00B

Ranking

n/a

PE Ratio

14.70

Stock Price

129.50

Market Cap Chart

Since November 2, 2004, Syngen Biotech's market cap has increased from 372.00M to 3.51B, an increase of 843.43%. That is a compound annual growth rate of 11.68%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	3.51B	1.97%
Dec 30, 2024	3.44B	-16.45%
Dec 29, 2023	4.12B	-6.17%
Dec 30, 2022	4.39B	43.36%
Dec 30, 2021	3.06B	4.63%
Dec 31, 2020	2.93B	-8.09%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	226.03B
Caliway Biopharmaceuticals	145.92B
Bora Pharmaceuticals Co., LTD.	90.53B
Lotus Pharmaceutical	72.59B
Lumosa Therapeutics	39.94B
Oneness Biotech	38.77B
Polaris Group	36.53B
Pegavision	30.34B

Market Cap Rankings